Integra LifeSciences
IART
280 hedge funds and large institutions have $4.16B invested in Integra LifeSciences in 2019 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 100 increasing their positions, 88 reducing their positions, and 23 closing their positions.
83% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 23
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
29% more call options, than puts
Call options by funds: $5.85M | Put options by funds: $4.52M
14% more repeat investments, than reductions
Existing positions increased: 100 | Existing positions reduced: 88
7% more funds holding
Funds holding: 262 → 280 (+18)
5% more capital invested
Capital invested by funds: $3.95B → $4.16B (+$210M)
1.8% less ownership
Funds ownership: 82.73% → 80.93% (-1.8%)
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$23.5M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$22.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21.1M |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
+$13.9M |
| 5 |
Millennium Management
New York
|
+$12.6M |
Top Sellers
IART Hedge Fund Activity: Q3 2019 in Review
280 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2019, worth a combined $4.16B — up 5.3% from $3.95B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new IART positions and 23 closed out — a net gain of 19 holders — while 100 added to existing stakes and 88 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $23.5M. The largest seller was Fidelity Investments, cutting an estimated $98.7M.
- 280 institutional investors held Integra LifeSciences (IART) as of Q3 2019, up from 262 in Q2 2019.
- Funds reported $4.16B of Integra LifeSciences stock for Q3 2019, up 5.3% quarter-over-quarter.
- 42 funds opened new Integra LifeSciences positions in Q3 2019 and 23 closed out, a net change of +19 holders.
- The largest Integra LifeSciences buyer in Q3 2019 was Point72 Asset Management, an estimated $23.5M added.
- The largest Integra LifeSciences seller in Q3 2019 was Fidelity Investments, an estimated $98.7M sold.
Based on aggregated 13F filings for Q3 2019.